Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00510926
Recruitment Status : Completed
First Posted : August 3, 2007
Last Update Posted : August 3, 2007
Information provided by:
University of Bologna

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : November 2006
Publications automatically indexed to this study by Identifier (NCT Number):